Carolina V. Arancibia-Cárcamo
University of Oxford(GB)Oxford BioMedica (United Kingdom)(GB)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Inflammatory Bowel Disease, Immune Cell Function and Interaction, IL-33, ST2, and ILC Pathways
Most-Cited Works
- → A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-β– and retinoic acid–dependent mechanism(2007)2,639 cited
- → The Short Chain Fatty Acid Butyrate Imprints an Antimicrobial Program in Macrophages(2019)969 cited
- → IL-23–responsive innate lymphoid cells are increased in inflammatory bowel disease(2011)622 cited
- → Interleukin-23 Restrains Regulatory T Cell Activity to Drive T Cell-Dependent Colitis(2008)401 cited
- → Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine(2021)349 cited
- → Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses(2020)336 cited